Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

To investigate the prognostic factors of stage Ⅰ-Ⅱ gastric cancer based on P53 mutation and tumor budding.

Pathology, research and practice - 1 Dec 2022

Li Fang, Li Shi, Wang Xinran, Liu Chang, Li Xiaoya, Li Yong, Liu Yueping

Abstract excerpt

BACKGROUND: P53 is a tumor suppressor and genome guardian factor, and tumor budding is a key link in tumor metastasis. The purpose of this study was to investigate P53 mutation and tumor budding in stage Ⅰ-Ⅱ gastric cancer, to explore the correlation with clinicopathological features, and to reveal the independent prognostic factors of gastric cancer. METHODS: The data of 588 patients with stage Ⅰ-Ⅱ gastric...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastrectomy
Share to Lymphatic Metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Staging

Share to Prognosis

Share to Stomach Neoplasms

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 36356333
DOI: 10.1016/j.prp.2022.154195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

To investigate the prognostic factors of stage Ⅰ-Ⅱ gastric cancer based on P53 mutation and tumor budding.PMID 36356333Read ↗

Tumor Budding and Prognosis in Gastric AdenocarcinomaSemantic proximity Read ↗

Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancerSemantic proximity Read ↗

Establish a novel tumor budding-related signature to predict prognosis and guide clinical therapy in colorectal cancerSemantic proximity Read ↗

Tumor Budding, Micropapillary Pattern, and Polyploidy Giant Cancer Cells in Colorectal Cancer: Current Status and Future ProspectsSemantic proximity Read ↗

Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.Semantic proximity Read ↗

Prognostic Impact of Tumor Budding on Moroccan Colon Cancer PatientsSemantic proximity Read ↗

Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.Semantic proximity Read ↗

Colorectal carcinomas with submucosal invasion (pT1): analysis of histopathological and molecular factors predicting lymph node metastasis.Semantic proximity Read ↗

Assessing the applicability and interobserver variability of tumor budding and poorly differentiated clusters in colorectal cancerSemantic proximity Read ↗

Systematic review of tumour budding and association with common mutations in patients with colorectal cancer.Semantic proximity Read ↗

A classification based on tumor budding and immune score for patients with hepatocellular carcinoma.Semantic proximity Read ↗

Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: Possible involvement of c‐MetSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.